Sugary drinks, fruit juices linked to higher risk of developing Type 2 diabetes among boys

A small, long-term study of almost 500 children in Massachusetts has found that regularly drinking sugary drinks and 100% fruit juices during childhood and adolescence may be linked to a higher risk of developing Type 2 diabetes among boys than girls, according to preliminary research to be presented at the American Heart Association’s Epidemiology and Prevention│Lifestyle and Cardiometabolic Scientific Sessions 2024, March 18- 21, in Chicago. The meeting offers the latest science on population-based health and wellness and implications for lifestyle.

“While these findings are preliminary, they support the existing evidence about the potential relationship between beverages with added sugar and long-term risk of Type 2 diabetes in children,” said lead investigator Soren Harnois-Leblanc, Ph.D., a registered dietitian and postdoctoral researcher in the department of population medicine at Harvard Pilgrim Health Care Institute and Harvard Medical School, both in Boston. “Pediatricians and other health care professionals should caution young patients and their parents about sugary drinks and fruit juices when discussing healthy eating habits.”

According to a 2022 American Heart Association fact sheet about sugary drinks, nearly two-thirds of children and adolescents in the U.S. consume at least one sugary drink, such as soda, lemonade or an energy drink, each day. It also notes that in addition to weight gain, eating too many foods with added sugars, especially from sugary drinks, raises the risk of developing heart disease, high blood pressure, Type 2 diabetes and tooth decay.

Using data from Project Viva, an ongoing long-term study of women and their children in eastern Massachusetts that began in 1999, researchers explored whether drinking sugary drinks, 100% fruit juices and eating fresh fruits were associated with markers for developing Type 2 diabetes. Researchers calculated the average consumption of sugary drinks, 100% fruit juices, and fresh fruits over childhood and adolescence based on dietary records and assessed their potential associations to three markers of Type 2 diabetes: insulin resistance, fasting blood glucose level and HbA1c levels. These markers were measured by a single blood test while fasting in late adolescence (approximately age 17).

The analysis found:

  • Each daily serving of sugary drinks (approx. 8 ounces) during childhood and adolescence among boys was associated with a 34% increase in insulin resistance; a 5.6 milligrams per deciliter (mg/dl) increase in fasting glucose levels; and a 0.12% increase in HbA1c levels in late adolescence.
  • Drinking 100% fruit juice throughout childhood and adolescence was linked to a 0.07% increase in HbA1c levels in late adolescence per daily serving of 100% fruit juice among the boys in the study, with only a slight increase in girls of 0.02%.
  • Eating fresh fruit during childhood and adolescence did not appear to have a positive or negative effect on the risk of developing Type 2 diabetes among the boys or girls in the study, according to Harnois-Leblanc.

The associations between regularly drinking sugar-sweetened beverage and insulin resistance, fasting blood glucose levels and elevated HbA1c levels among boys persisted when other health, family and social factors were considered. These factors included socioeconomic status; child’s and mother’s body mass index; mother’s age at time of child’s birth; maternal and paternal history of Type 1 or Type 2 diabetes; overall diet quality and other lifestyle behaviors.

“Although several aspects of biology and behaviors differ between boys and girls, I would have expected to also find an association between sugar-sweetened beverages and fruit juice intake and the increases in insulin resistance, glycemia and HbA1c levels in late-adolescent girls. I was also surprised that eating whole fruits did not reduce the levels of these markers of Type 2 diabetes,” Harnois-Leblanc said.

“The next steps are to use more advanced statistical tools to enable us to better understand the potential causal role of sugary drinks and fruit juices, and to examine whether the relationships may also differ among children by race and/or ethnicity.”

Study background and details:

  • Researchers analyzed data of children of the 2,128 pregnant women who had children while enrolled in Project Viva. 972 of the children met criteria for inclusion in this study (parent-completed questionnaires at the child’s age-3 examination and no personal or parental history of Type 1 or Type 2 diabetes, assessed separately from parental history of Type 2 diabetes). Of the 972 children, 455 had a fasting blood sample collected at a research visit in late adolescence, Harnois-Leblanc noted.
  • 240 of the children in the study were girls and 215 were boys.
  • Project Viva is a long-term study of women and their children in eastern Massachusetts that began enrollment in 1999. The study is focused on improving maternal and child health by examining the potential impact of various life and health factors during and after pregnancy on the mother’s health and their children’s health, including a review of diet and nutrition. Children were followed from birth to late adolescence, up to age 20 at most recent follow-up.
  • Researchers evaluated the frequency of drinking sugary drinks, fruit juices and eating fresh fruit (based on standard serving sizes) from questionnaires completed by the parent at the child’s age of approximately 3, 8 and 13 years old; and measured fasting blood glucose, insulin and HbA1c levels in late adolescence (average age of 17.4 years).

The study had several limitations. Although it found an association between regularly drinking sugary drinks and fruit juices and the development of markers for Type 2 diabetes, it could not prove that the drinks caused Type 2 diabetes. Additionally, the relatively small number of study participants may have affected the strength of the association found between sugary drinks and fruit juices and the increased risk of developing Type 2 diabetes.

“Diet and cardiometabolic health are complex, with many factors varying over time and interacting in different ways, and this study represents one small piece of this puzzle,” Harnois-Leblanc said.

American Heart Association nutrition committee member Penny M. Kris-Etherton, Ph.D., R.D., FAHA, said, “This study has shown that greater sugar sweetened beverage intake, including fruit juice, throughout childhood and adolescents is associated with higher markers of diabetes risk in late adolescents in boys but not girls. It is striking that many measures of Type 2 diabetes risk were increased in boys at such an early age.”

Kris-Etherton, an emeritus professor of nutritional sciences at Penn State University, was also a co-author of the Association’s 2018 science advisory on low-calorie sweetened beverages and cardiometabolic health.

“Importantly, although fruit intake did not appear to be protective, it nonetheless was not associated with increased Type 2 diabetes risk,” she said. “These findings support the current dietary recommendations of the Association, and many organizations, to limit or eliminate drinking sugar sweetened beverages and instead consume whole fruits, which are high in so many nutrients especially the shortfall nutrients in the average American diet.” (Shortfall nutrients are the vitamins and nutrients that people are missing each day from the foods they eat; long-term deficiencies in some vitamins and nutrients have been linked to adverse health outcomes.)

The health care resource called Know Diabetes by Heart, developed by the American Heart Association and the American Diabetes Association, provides information about preventing heart disease and stroke while living with Type 2 diabetes. The initiative aims to raise awareness and understanding of the link between Type 2 diabetes and cardiovascular disease, provide resources and support to help people better manage their risk for heart disease and stroke, support health care professionals by sharing the latest clinical guidelines and science and engage health systems to improve quality of care for people with Type 2 diabetes.

Powered by WPeMatico

Receipt of MMR vaccine linked to reduced rate of antibiotic treatment in kids under 2: Study

A recent register-based cohort study conducted across Denmark, Finland, Norway, and Sweden aimed to investigate the potential non-specific effects of the measles, mumps, and rubella (MMR) vaccine given after the third dose of diphtheria-tetanus-acellular pertussis (DTaP3) vaccine. Previous research has suggested that MMR vaccination may have beneficial non-specific effects, such as reducing the risk of infections not targeted by the vaccine.

The study, conducted by Lise Gehrt and colleagues and published in the journal Vaccine. It utilized Cox proportional hazards regression with age as the underlying timescale and vaccination status as a time-varying exposure. This methodology was employed to estimate covariate-adjusted Hazard Ratios (aHRs) and inverse probability of treatment weighted (IPTW) HRs of antibiotic treatments. Additionally, summary estimates were calculated using random-effects meta-analysis. The primary objective of the study was to investigate whether receiving the MMR vaccine after DTaP3 was linked to reduced rates of antibiotic treatments in children.

The study included 831,287 children who had received DTaP3 but not yet MMR vaccine. The key findings of the study were:

  • Across all Nordic countries, receipt of the MMR vaccine after DTaP3 was associated with reduced rates of antibiotic treatments.

  • The adjusted Hazard Ratios (aHRs) for antibiotic treatments were 0.92 in Denmark, 0.92 in Finland, 0.84 in Norway, and 0.87 in Sweden.

  • The summary estimate across all countries was 0.89, indicating an 11% lower rate of antibiotic treatments associated with MMR vaccination after DTaP3.

  • A negative control exposure analysis comparing children vaccinated with DTaP3 versus two doses of DTaP further supported these findings.

The study concluded that MMR vaccination after DTaP3 was associated with an 11% lower rate of antibiotic treatments across the Nordic countries. While the negative control analysis suggested some residual confounding. The findings suggest that the potential non-specific effects of MMR vaccine on reducing antibiotic use are of limited clinical and public health significance for milder infections treated out-of-hospital in the Nordic setting. These results contribute to our understanding of the broader impacts of childhood vaccinations and highlight the importance of ongoing research in this area.

Reference:

Gehrt, L., Englund, H., Laake, I., Nieminen, H., Möller, S., Feiring, B., Lahdenkari, M., Trogstad, L., Benn, C. S., & Sørup, S. Is vaccination against measles, mumps, and rubella associated with reduced rates of antibiotic treatments among children below the age of 2 years? Nationwide register-based study from Denmark, Finland, Norway, and Sweden. Vaccine,2024. https://doi.org/10.1016/j.vaccine.2024.03.026

Powered by WPeMatico

AI can now detect COVID-19 in lung ultrasound images: Study

Artificial intelligence can spot COVID-19 in lung ultrasound images much like facial recognition software can spot a face in a crowd, new research shows.

The findings boost AI-driven medical diagnostics and bring health care professionals closer to being able to quickly diagnose patients with COVID-19 and other pulmonary diseases with algorithms that comb through ultrasound images to identify signs of disease.

The findings, newly published in Communications Medicine, culminate an effort that started early in the pandemic when clinicians needed tools to rapidly assess legions of patients in overwhelmed emergency rooms.

“We developed this automated detection tool to help doctors in emergency settings with high caseloads of patients who need to be diagnosed quickly and accurately, such as in the earlier stages of the pandemic,” said senior author Muyinatu Bell, the John C. Malone Associate Professor of Electrical and Computer Engineering, Biomedical Engineering, and Computer Science at Johns Hopkins University. “Potentially, we want to have wireless devices that patients can use at home to monitor progression of COVID-19, too.”

The tool also holds potential for developing wearables that track such illnesses as congestive heart failure, which can lead to fluid overload in patients’ lungs, not unlike COVID-19, said co-author Tiffany Fong, an assistant professor of emergency medicine at Johns Hopkins Medicine.

“What we are doing here with AI tools is the next big frontier for point of care,” Fong said. “An ideal use case would be wearable ultrasound patches that monitor fluid buildup and let patients know when they need a medication adjustment or when they need to see a doctor.”

The AI analyzes ultrasound lung images to spot features known as B-lines, which appear as bright, vertical abnormalities and indicate inflammation in patients with pulmonary complications. It combines computer-generated images with real ultrasounds of patients-including some who sought care at Johns Hopkins.

“We had to model the physics of ultrasound and acoustic wave propagation well enough in order to get believable simulated images,” Bell said. “Then we had to take it a step further to train our computer models to use these simulated data to reliably interpret real scans from patients with affected lungs.”

Early in the pandemic, scientists struggled to use artificial intelligence to assess COVID-19 indicators in lung ultrasound images because of a lack of patient data and because they were only beginning to understand how the disease manifests in the body, Bell said.

Her team developed software that can learn from a mix of real and simulated data and then discern abnormalities in ultrasound scans that indicate a person has contracted COVID-19. The tool is a deep neural network, a type of AI designed to behave like the interconnected neurons that enable the brain to recognize patterns, understand speech, and achieve other complex tasks.

“Early in the pandemic, we didn’t have enough ultrasound images of COVID-19 patients to develop and test our algorithms, and as a result our deep neural networks never reached peak performance,” said first author Lingyi Zhao, who developed the software while a postdoctoral fellow in Bell’s lab and is now working at Novateur Research Solutions. “Now, we are proving that with computer-generated datasets we still can achieve a high degree of accuracy in evaluating and detecting these COVID-19 features.”

Reference:

Lingyi Zhao, Tiffany Clair Fong, Muyinatu A. Lediju Bell. Detection of COVID-19 features in lung ultrasound images using deep neural networks. Communications Medicine, 2024; 4 (1) DOI: 10.1038/s43856-024-00463-5.

Powered by WPeMatico

Vital pulp therapy tied to less postoperative pain compared to single visit root canal treatment: Study

Vital pulp therapy tied to less postoperative pain compared to single-visit root canal treatment suggests a new study published in the JADA

This systematic review investigated whether vital pulp therapy and root canal treatment (RCT) promote different postoperative pain. The authors searched PubMed, Cochrane Library, Embase, and Latin American and Caribbean Health Sciences Literature databases for studies published through June 30, 2022. The authors included randomized clinical trials if they reported on the assessment of postoperative pain after direct pulp capping, partial pulpotomy, pulpotomy, or single-visit RCT. The authors assessed the frequency of no, mild, moderate, and severe postoperative pain. They conducted meta-analyses to compare postoperative pain after full pulpotomy (PULP) and RCT. Results: The qualitative synthesis included 57 studies, and the authors conducted meta-analysis of 3. PULP leads to more asymptomatic cases (relative risk [RR], 1.06; 95% CI, 1.01 to 1.11; P < .01; I2 = 67%) and to a lower occurrence of mild (RR, 0.89; 95% CI, 0.79 to 0.99; P < .04; I2 = 37%) and moderate (RR, 0.70; 95% CI, 0.51 to 0.95; P < .02; I2 = 57%) postoperative pain than RCT. The frequency of severe pain was very low for both vital pulp therapy and RCT. Moderate to severe postoperative pain was more common at 48 hours through 72 hours after RCT and up to 36 hours after PULP. Pain intensity after PULP was higher using calcium-enriched material compared with using mineral trioxide aggregate at 12, 18, and 36 hours (P < .001). PULP showed a significantly higher incidence of no pain and a lower incidence of mild and moderate pain than single-visit RCT. Clinical decisions for RCT or PULP should not be based on differences in postoperative pain. When analgesia is indicated, it probably should be limited to a short time after PULP.

Reference:

Signor B, Poli Kopper PM, Aspesi M, Münchow EA, Scarparo RK. Postoperative pain after single-visit root canal treatment or vital pulp therapy: A systematic review and meta-analysis. J Am Dent Assoc. 2024 Feb;155(2):118-137.e1. doi: 10.1016/j.adaj.2023.11.008. PMID: 38325970.

Keywords:

Vital pulp therapy, postoperative pain, single visit root, canal treatment, Dental pulp capping, endodontics, pulpectomy, pulpotomy, postoperative pain, root canal treatment, JADA

Powered by WPeMatico

Breastfeeding mothers who exercise pass on beneficial hormone to their children: Study

Although women have breastfed since the beginning of time, there is very little scientific research on how exercise affects breast milk.

Online forums for pregnant women and new mothers are full of questions about this exact issue:

Can exercise cause breast milk to go sour? What happens to breast milk if you do high-intensity interval training? Will strenuous exercise affect your milk supply?

“There are so many myths about exercise and breast milk. We simply need more knowledge,” says researcher Trine Moholdt at the Norwegian University of Science and Technology (NTNU).

She heads several international research projects on how exercise can prevent and treat lifestyle diseases.

Limiting overweight in children

Last year, Moholdt received NOK 23.5 million from the EU and NTNU to find out if breast milk is extra healthy for babies if mothers exercise.

“The primary aim of our research is to find out if we can limit the development of overweight in children,” says Moholdt.

In 2020, the World Health Organization estimated that 39 million children under the age of five were overweight or obese. They also found that the incidence of overweight and obesity among children and adolescents aged 5–19 rose from four per cent in 1975 to 18 per cent in 2018.

Research shows that one possible contributing factor in the rapid rise in obesity in children is that nutrition during the early phase of life partially determines your health later in life.

“In fact, the period from conception to two years of age is considered the most critical period for possible development of obesity later in life,” says Moholdt.

Important hormone

Twenty new mothers have given 240 samples of breast milk. The samples were taken before and at specific times after two exercise sessions, and then compared with the corresponding times after the participants had been more sedentary.

The first piece of the puzzle has been identified, and it concerns a hormone called adiponectin.

This hormone regulates the body’s metabolism to ensure a supply of energy and substances that the body needs to function.

It is probable that this hormone is absorbed through the intestines of breastfeeding babies, thus changing how their metabolism functions.

Having low levels of this hormone is associated with insulin resistance and type 2 diabetes.

Good for the child

Moholdt’s study shows that mothers who did high-intensity interval training had higher levels of this hormone in their breast milk after their exercise session.

It is the first time that someone has investigated the effect exercise has on this hormone in breast milk.

“The hormone is secreted from fatty tissue and enters the bloodstream, and much of what is in the blood goes into the milk. We were not that surprised by the findings, but now we know for certain,” says Moholdt.

Intense exercise gives the best effect

The study shows that moderately intense exercise did not have the same effect on this particular hormone.

“Intense exercise led to a higher response. In my opinion, new mothers don’t have to worry about lactic acid in their breast milk. There is no research suggesting that this is unfortunate, and lactic acid is energy-rich,” says Moholdt.

One of the reasons why the WHO recommends breastfeeding during the first six months of life is that breast-fed children are less likely to be overweight and obese than formula-fed children. However, new research shows that the composition of breast milk varies between mothers who have high and low body mass indexes, and that differences in breast milk composition can play a role in the transfer of obesity from mother to child.

“We now have the first result of all the work we are doing, and many more results are on the way. It will be very exciting going forward,” says Moholdt.

Reference:

Mads Holmen, Guro F. Giskeødegård, Trine Moholdt, High-intensity exercise increases breast milk adiponectin concentrations: a randomised cross-over study, Frontiers in Nutrition, https://doi.org/10.3389/fnut.2023.1275508

Powered by WPeMatico

Uterine fibroids undergoing radiofrequency ablation or myomectomy have similar live birth rates: Study

The ULTRA (Uterine Leiomyoma Treatment With Radiofrequency Ablation) study is a comprehensive investigation comparing pregnancy outcomes between two common surgical interventions for symptomatic uterine leiomyomas: laparoscopic radiofrequency ablation and myomectomy. Uterine leiomyomas, or fibroids, are prevalent benign tumors affecting many women during their reproductive years. These fibroids can lead to fertility issues and pose risks for adverse pregnancy outcomes, necessitating effective treatment options. Laparoscopic radiofrequency ablation and myomectomy are two surgical options used to treat symptomatic fibroids, but their impact on pregnancy outcomes remains unclear.

This study was published in the journal Obstetrics & Gynaecology by Allen A. and colleagues. In the study, 539 premenopausal women over 21 years with symptomatic fibroids were enrolled to evaluate the impact of radiofrequency ablation and myomectomy on pregnancy outcomes. Participants were followed longitudinally for up to 5 years post-surgery, with pregnancy incidence and outcomes assessed every 6 months.

Preliminary findings from the ULTRA study revealed insights into the incidence of pregnancy and its outcomes following surgical intervention:

  • Among the 37 participants who conceived post-surgery, a total of 43 pregnancies were reported, with 22 pregnancies occurring after radiofrequency ablation and 21 after myomectomy.

  • The baseline miscarriage rate in the study population was 33.3%.

  • In the radiofrequency ablation group, 40.9% of pregnancies ended in first-trimester miscarriage, while 50.0% resulted in live births.

  • In the myomectomy group, 42.9% of pregnancies ended in first-trimester miscarriage, with 57.1% resulting in live births.

  • There were no significant differences observed in the likelihood of live birth or miscarriage between the two treatment groups.

  • Among the live births in the radiofrequency ablation group, 45.5% were achieved through vaginal delivery.

In conclusion, the ULTRA study demonstrates that full-term pregnancy and vaginal delivery are achievable outcomes following radiofrequency ablation of uterine leiomyomas. However, both treatment groups exhibited higher miscarriage rates than expected for women in the study age group. Continued data collection in the ULTRA study aims to provide further clarity on pregnancy outcomes following different fibroid treatment methods, contributing to enhanced clinical decision-making for women with symptomatic fibroids.

Reference:

Allen, A., Schembri, M., Parvataneni, R., Waetjen, L. E., Varon, S., Salamat-Saberi, N., Tassone, S., Williams, N., Kho, K. A., & Jacoby, V. L. (2024). Pregnancy outcomes after laparoscopic radiofrequency ablation of uterine leiomyomas compared with myomectomy. Obstetrics and Gynecology, 10.1097/AOG.0000000000005548. https://doi.org/10.1097/aog.0000000000005548

Powered by WPeMatico

Intermittent fasting increases the risk of death from cardiovascular causes? Study sparks debate

USA: A recent study of US adults revealed that time-restricted eating (TRE)/intermittent fasting with eating duration <8 hours is significantly associated with a higher risk of cardiovascular mortality in the general population and people with cancer or cardiovascular disease.

The findings, presented at the AHA’s Epidemiology, Prevention, Lifestyle, and Cardiometabolic Health Scientific Sessions in Chicago, IL, do not support the long-term use of 16:8 time-restricted eating for preventing cardiovascular death.

The analysis from the National Health and Nutrition Examination Survey (NHANES) showed that eating during an 8-hour or smaller window throughout the day was tied to a 91% higher risk of death from cardiovascular causes; greater risks were observed in those with cancer or cardiovascular disease (CVD).

Time-restricted eating has gained popularity as a dietary intervention that limits daily food intake to a 4- to 12-hour window. Most short-term randomized controlled trials (RCTs) reported that TRE improved cardiometabolic risk profiles. However, there is no knowledge of whether TRE is associated with long-term hard endpoints.

Against the above background, Meng Chen, Sch of Public Health, Shanghai Jiao Tong Univ Sch of Med, Shanghai, China, and colleagues assessed the hypothesis that TRE is linked with a reduced risk of cause-specific and all-cause mortality.

For this purpose, the researchers included participants aged at least 20 years who completed two valid 24-hour dietary recalls and reported usual intake in both recalls from the NHANES in 2003-2018. Mortality status as of December 2019 was obtained through linkage to the National Death Index.

An eating occasion needs consumption of more than 5 kcal of beverages or foods. For each day, the eating duration between the last and first eating occasion was calculated. The average duration of two recall days defined typical eating duration which was then divided as <8, 8-<10, 10-<12, 12-16 (reference group; mean duration in US adults), and >16 hours.

Multivariable Cox proportional hazard models were employed to estimate the association of eating duration with cause-specific and all-cause mortality in the overall sample and among adults with cancer or CVD.

Among 20,078 adults included, the weighted mean age was 48.5 years, 50.0% were men, and 73.3% were non-Hispanic White.

The study led to the following findings:

  • During a median follow-up of 8.0 years, 2797 all-cause deaths occurred, including 840 cardiovascular deaths and 643 cancer deaths.
  • Compared with eating 12-16 hours, eating duration <8 hours was significantly associated with an increased risk of cardiovascular mortality (HR, 1.96); this association was also observed in adults with cardiovascular disease (HR, 2.06) and adults with cancer (HR, 2.72).
  • Other eating durations were not associated with cardiovascular mortality, except for eating duration of 8-<10 hours in people with cardiovascular disease (HR, 1.64).
  • No significant associations were found between eating duration and all-cause or cancer mortality in the overall sample and diseased subsamples, except that eating duration >16 hours was associated with a lower risk of cancer mortality in people with cancer (HR, 0.46).

In conclusion, among US adults, TRE with eating duration <8 hours was significantly associated with a higher risk of cardiovascular mortality in the general population and people with cancer or CVD. These findings do not support the long-term use of 16:8 TRE for preventing cardiovascular death.

However, the authors acknowledged that the study findings need replication and warned that no specific dietary advice around restricted eating/intermittent fasting should be given based on their study alone.

Reference:

Chen M, Zhong VW. Association between time-restricted eating and all-cause and cause-specific mortality. Presented at: Epidemiology, Prevention, Lifestyle, and Cardiometabolic Health Scientific Sessions. Chicago, IL. March 18, 2024.

Powered by WPeMatico

Combined PET-MRI scan could improve treatment for patients with early breast cancer: Study

Using a combined scanning technique on patients with early-stage breast cancer improved treatment in almost three out of ten cases in a trial presented at the 14th European Breast Cancer Conference.

Using the combined positron emission tomography-magnetic resonance imaging (PET-MRI) scans enabled doctors to spot signs that a patient’s tumour had begun to spread, meaning they could benefit from alternative treatment, such as chemotherapy or a different type of surgery.

The research was presented by Dr Rosa Di Micco, a breast surgeon at IRCCS San Raffaele University and Research Hospital in Milan, Italy. She said: “The standard approach for patients with early breast cancer includes mammography, ultrasound, and sometimes MRI. Combined PET-MRI is a relatively new approach, so it’s generally only used in clinical research.”

The new study led by Professor Oreste Gentilini includes 205 patients who were being treated at San Raffaele Hospital between July 2020 and October 2023. Before being offered breast-conserving surgery to remove the tumour, each patient was given a PET-MRI scan to look for signs of cancer spread in the affected breast, the surrounding area and the rest of the body.

In 57 out of the 205 patients (27.8%), their planned treatment was altered based on the results of the PET-MRI scan. Of these, 18 had chemotherapy as a first-line treatment and the remaining 39 had different surgical approaches, including mastectomy, removal of extra lymph nodes and surgery on both breasts. In 12 out of the 57 patients (21%), additional tumour tissue removed turned out to be benign.

Dr Di Micco said: “Our research suggests that for patients with early breast cancer, the addition of a PET-MRI scan to standard care could help us make more informed decisions about the best treatment pathway. However, results of this technique are still affected by a high percentage of false positives and should therefore be confirmed by further testing.”

Professor Gentilini said: “These are early results from an ongoing study, but they suggest that a PET-MRI scan could refine treatment for some breast cancer patients. They also suggest that this is an area where more research could be beneficial.”

Dr Di Micco and her colleagues are also beginning a new study using a slightly different PET-MRI approach that should help detect breast cancer cells that grow in response to the female hormone oestrogen. This could be particularly helpful for patients with lobular breast cancer, which can be harder to see on mammograms or ultrasounds scans.

Professor Michail Ignatiadis from the Institut Jules Bordet in Brussels, Belgium, is Chair of the 14th European Breast Cancer Conference and was not involved in the research. He said: “Once complete, this will be one of the largest studies of its kind looking at PET-MRI before surgery for patients with early breast cancer. We look forward to more results from this study, but these findings suggest that PET-MRI could help spot early signs that breast cancer has begun to spread. Spotting these signs might give people the best chance of long-term survival. We now need studies to prospectively test this hypothesis.”

Reference:

A combined PET-MRI scan could improve treatment for patients with early breast cancer, European Organisation for Research and Treatment of Cancer,  Meeting: 14th European Breast Cancer Conference (EBCC14).

Powered by WPeMatico

Edoxaban as good as Apixaben for VTE prevention in elderly with nonvalvular AF: Study

In a recent study that could influence the management of nonvalvular atrial fibrillation among the elderly, recent outcomes unveiled the comparative effectiveness and safety of edoxaban against apixaban. This research was carried out using data from the United Kingdom Clinical Practice Research Datalink spanning from 2015 to 2021.

Nonvalvular atrial fibrillation is a common heart rhythm irregularity that increases the risk of stroke and systemic embolism in the elderly. Anticoagulants like edoxaban and apixaban were prescribed to reduce these risks. However, the relative benefits and risks of these medications in patients above 80 years had not been thoroughly compared until now.

This meticulous analysis encompassed a total of 7,251 new users of edoxaban and a total of 39,991 users of apixaban. The advanced statistical techniques including the propensity score fine stratification and the weighting were adjusted for potential confounders that ensure the reliability of the results.

The primary outcomes of interest were the incidence of ischemic stroke, transient ischemic attack, systemic embolism and major bleeding events. The secondary outcomes included all-cause mortality and a composite outcome that covered both thromboembolic events and major bleeding incidents like the gastrointestinal and intracranial hemorrhages.

The outcomes of this study indicate that both edoxaban and apixaban express similar effectiveness in preventing thromboembolic events, with adjusted incidence rates of 20.38 and 19.22 per 1,000 person-years, respectively. However, a marked difference was observed in the safety profile of the two drugs. Edoxaban users experienced a significantly increased rate of major bleeding events when compared to the individuals on apixaban, with adjusted rates of 45.57 versus 31.21 per 1000 person-years. This translated to a 42% elevated risk associated with edoxaban.

Also, this comprehensive study noticed a 21% higher risk for the composite outcome of serious adverse events in patients who were taking edoxaban. Despite these differences in safety, the risk of all-cause mortality remained similar between the two groups. While both medications offered comparable effectiveness in preventing thromboembolic events, the increased risk of major bleeding with edoxaban cannot be overlooked. Overall, this study underlines the importance of individualized patient care and the need for careful consideration when prescribing anticoagulants to the very elderly who are vulnerable to the adverse effects of these medications.

Reference:

Chiv, R., Beradid, S., Suissa, S., & Renoux, C. (2024). Effectiveness and Safety of Edoxaban Compared With Apixaban in Elderly Patients With Nonvalvular Atrial Fibrillation: A Real-World Population-Based Cohort Study. In Stroke. Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1161/strokeaha.123.045098

Powered by WPeMatico

Antipyretic therapy reduces overheating during exercise in people with MS, reveals study

A recent study published in the Journal of Neurology found that antipyretic (fever-reducing) treatments before exercise can significantly reduce the risk of overheating, a common deterrent to physical activity in people with multiple sclerosis (pwMS). This research opens new avenues for to manage MS symptoms and enhance exercise participation among pwMS.

Multiple sclerosis is a chronic condition that affects the central nervous system and often leads to sensitivity to heat in many individuals, which in turn makes exercise and physical activity a challenge due to the risk of overheating. However, regular exercise is crucial for pwMS which offers benefits such as improved strength, mood and overall quality of life. The study explored the effectiveness of pre-exercise antipyretic treatment in managing body temperature and enhancing exercise tolerance to address the challenge of heat sensitivity.

This randomized controlled trial involved adults over the age of 18 diagnosed with relapsing-remitting MS, who reported heat sensitivity during exercise. The participants were randomly assigned to one of six sequences, and were subjected to receive doses of either aspirin, acetaminophen or a placebo before undertaking a maximal exercise test. The primary outcomes measured were changes in body temperature and total time to exhaustion (TTE), with secondary outcomes focusing on physiological and patient-reported outcomes (PROs).

The results showed a significant reduction in body temperature increases after administering aspirin and acetaminophen when compared to placebo. Aspirin led to a negligible increase in body temperature, while acetaminophen showed a modest increase, both significantly lower than the placebo group. The treatments did not significantly affect TTE during the exercise tests which suggests that while antipyretic medications can effectively manage body temperature, they do not necessarily extend exercise duration in a maximal exercise setting.

Also, aspirin demonstrated benefits across all secondary outcomes including physiological markers of exercise productivity and PROs related to fatigue, pain and perceived exertion when compared to placebo. Acetaminophen also showed consistent benefits that highlights the potential of these common medications to enhance exercise experiences for pwMS. Overall, the research offers a practical solution to one of the significant barriers to physical activity underwent by individuals with MS by demonstrating that antipyretic treatments can reduce overheating during exercise.

References:

Leavitt, V. M., Tozlu, C., Nelson, K. E., Boehme, A. K., Donnelly, J. E., Aguerre, I., Spinner, M., Riley, C. S., Stein, J., & Onomichi, K. (2024). A randomized controlled trial of oral antipyretic treatment to reduce overheating during exercise in adults with multiple sclerosis. In Journal of Neurology. Springer Science and Business Media LLC. https://doi.org/10.1007/s00415-023-12147-6

Powered by WPeMatico